Sinergium Biotech, an Argentinian manufacturer, will lead this effort, leveraging the WHO and MPP mRNA Technology Transfer Programme to achieve the objective.
The self-test version, specifically designed for use by lay users, provides individuals with a single kit containing the components that are needed to perform the self-test.
A new report reveals that alcohol is a leading cause of death through drunk driving, violence, and numerous diseases.
Health officials reveal that 80 per cent of infected individuals may exhibit mild symptoms or remain asymptomatic, making prompt medical attention crucial to prevent severe cases and death.
The continent still falls short of the WHO’s recommended collection target of 10 units of blood per 1000 people.
WHO urges stronger measures to protect African youth from tobacco industry’s influence, noting seven million young users and ongoing health risks.
STIs, including multi-resistant gonorrhoea, are increasing globally, with the highest spikes in the Americas and Africa.
The World Health Organization (WHO) has added a new weapon to the fight against dengue, a mosquito-borne illness affecting millions globally.
An estimated $8bn is required annually for Nigeria to sustain its fight against the HIV/AIDS epidemic.
Namibia’s achievement follows a concerted strategy to curb the transmission of hepatitis B, HIV, and syphilis.
With malaria remaining a significant public health burden in Nigeria, experts stress the importance of a fresh approach, emphasizing the need for improved data collection and sharing.
Eight African countries now offer the lifesaving malaria vaccine, with Benin, Liberia, and Sierra Leone joining the fight. This WHO-backed effort aims to significantly reduce childhood illness and death from malaria.
Study reveals vaccines’ unparalleled impact, saving six lives per minute over 50 years.
WHO’s vaccine prequalification aims to guarantee the safety and efficacy of vaccines utilized in immunization initiatives.